Cargando…

Using Genetic Testing at Cancer Diagnosis for Breast Cancer Control

Detalles Bibliográficos
Autores principales:	Sun, Li, Wei, Xia, Manchanda, Ranjit, Legood, Rosa, Yang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433755/ https://www.ncbi.nlm.nih.gov/pubmed/36060444 http://dx.doi.org/10.46234/ccdcw2022.148

Ejemplares similares

Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China
por: Sun, Li, et al.
Publicado: (2022)

Population based germline testing for primary cancer prevention
por: Manchanda, Ranjit, et al.
Publicado: (2018)

Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review
por: Wei, Xia, et al.
Publicado: (2022)

Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis
por: Gaba, Faiza, et al.
Publicado: (2023)

Quality of Life after Risk-Reducing Hysterectomy for Endometrial Cancer Prevention: A Systematic Review
por: Oxley, Samuel, et al.
Publicado: (2022)

A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
por: Sun, Li, et al.
Publicado: (2019)

Population‐based genetic testing for cancer susceptibility genes: quo vadis?
por: Manchanda, Ranjit, et al.
Publicado: (2022)

Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews
por: Gaba, Faiza, et al.
Publicado: (2022)

Special Issue “Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer”
por: Manchanda, Ranjit
Publicado: (2022)

Do current family history-based genetic testing guidelines contribute to breast cancer health inequities?
por: Jakuboski, Samantha H., et al.
Publicado: (2022)

Cost–effectiveness of risk-based breast cancer screening programme, China
por: Sun, Li, et al.
Publicado: (2018)

Telemammography for breast cancer screening: a cost-effective approach in Argentina
por: Malek Pascha, Victoria Alba, et al.
Publicado: (2021)

Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Pennington, Mark, et al.
Publicado: (2016)

Global treatment costs of breast cancer by stage: A systematic review
por: Sun, Li, et al.
Publicado: (2018)

DDT and Breast Cancer
por: Tarone, Robert E.
Publicado: (2008)

Preimplantation genetic testing for aneuploidy: challenges in clinical practice
por: Yang, Hui, et al.
Publicado: (2022)

GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies
por: Nguyen, Khoa, et al.
Publicado: (2022)

Association of Hypertension and Breast Cancer: Antihypertensive Drugs as an Effective Adjunctive in Breast Cancer Therapy
por: Fan, Yuanyuan, et al.
Publicado: (2022)

Genetic modifiers of p53: opportunities for breast cancer therapies
por: Majhi, Prabin Dhangada, et al.
Publicado: (2023)

Bisphenol, npcRNAs and Utero-Ovarian Feed-Back Control of Breast Cancer Chemosensitivity
por: Yarpuzlu, Aysegul
Publicado: (2009)

DDT and Breast Cancer Trends
por: Tarone, Robert E.
Publicado: (2008)

Breast cancer survivorship in India
por: D’Souza, Rebecca Brian, et al.
Publicado: (2021)

Urinary Biomarkers for Early Diagnosis of Lung Cancer
por: Gasparri, Roberto, et al.
Publicado: (2021)

Improving tuberculosis diagnosis: Better tests or better healthcare?
por: Datta, Sumona, et al.
Publicado: (2017)

Birth Size and the Pathogenesis of Breast Cancer
por: Lagiou, Pagona, et al.
Publicado: (2008)

Breast Cancer Environment Centers and Advocacy
por: Wolff, Mary S., et al.
Publicado: (2011)

Progress in targeted therapy for breast cancer
por: Ju, Jie, et al.
Publicado: (2018)

An alternative model for (breast) cancer predisposition
por: Teugels, Erik, et al.
Publicado: (2017)

Increased Early Cancer Diagnosis: Unveiling Immune-Cancer Biology to Explain Clinical “Overdiagnosis”
por: Wauchope, Bruce A., et al.
Publicado: (2023)

Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study
por: Chandrasekaran, Dhivya, et al.
Publicado: (2021)

Perspectives of breast cancer etiology: synergistic interaction between smoking and exogenous hormone use
por: Zhu, Hong-Hong, et al.
Publicado: (2011)

Management of breast cancer brain metastases: Focus on human epidermal growth factor receptor 2-positive breast cancer
por: Yuan, Peng, et al.
Publicado: (2017)

Challenges and Pragmatic Solutions in Pre-Test and Post-Test Genetic Counseling for Prenatal Exome Sequencing
por: Diderich, Karin E M, et al.
Publicado: (2023)

How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?
por: Horgan, Denis, et al.
Publicado: (2022)

Genomic landscape of inflammatory breast cancer identifies potential actionable genetic alterations
por: Bertucci, François, et al.
Publicado: (2020)

Endocrine resistant breast cancer: brain metastasis
por: Willman, Matthew, et al.
Publicado: (2022)

Melanocytic Nevi as Biomarkers of Breast Cancer Risk
por: Fuhrman, Barbara, et al.
Publicado: (2014)

Breast cancer in Brazil: epidemiology and treatment challenges
por: Cecilio, Adma Poliana, et al.
Publicado: (2015)

Current status of breast cancer prevention in China
por: Wang, Fei, et al.
Publicado: (2015)

Internet tools to enhance breast cancer care
por: Shachar, Shlomit Strulov, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7ms7qljn6idnlc4f68e2e2p3hv